| | | | | | | | | | | | | | | | |
| |
![Collapse](/DXR.axd?r=1_87-p7f1t) | Issue Date FY: 2024 ( Subtotal = $62,105,929 ) (Continued on the next page) |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS121608 | Development of Mass Spectrometry Strategies to Decipher Dynamic Lysosomal Dysfunctions in Frontotemporal Dementia | 001 | 4 | NIH | 4/10/2024 | $27,128 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS121608 | Development of Mass Spectrometry Strategies to Decipher Dynamic Lysosomal Dysfunctions in Frontotemporal Dementia | 000 | 4 | NIH | 3/19/2024 | $348,776 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA247684 | Targeting Fanconi Anemia pathway to overcome platinum drug resistance in ovarian cancer | 001 | 4 | NIH | 4/17/2024 | $21,796 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA247684 | Targeting Fanconi Anemia pathway to overcome platinum drug resistance in ovarian cancer | 000 | 4 | NIH | 3/20/2024 | $392,347 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01AI153110 | Design and development of HDAC11-specific chemical inhibitors for disease treatments | 001 | 4 | NIH | 5/30/2024 | $69,752 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01AI153110 | Design and development of HDAC11-specific chemical inhibitors for disease treatments | 000 | 4 | NIH | 2/14/2024 | $627,765 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U24HD036801 | NICHD Maternal-Fetal Medicine Units (MFMU) Network: Data CoordinatingCenter | 008 | 27 | NIH | 4/30/2024 | $400,069 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | U24HD036801 | NICHD Maternal-Fetal Medicine Units (MFMU) Network: Data CoordinatingCenter | 007 | 27 | NIH | 3/22/2024 | $3,600,621 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01HL158305 | Lipid raft therapy – a novel therapeutic approach for HIV-associated cardiometabolic co-morbidities | 001 | 4 | NIH | 6/20/2024 | $62,704 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01HL158305 | Lipid raft therapy – a novel therapeutic approach for HIV-associated cardiometabolic co-morbidities | 000 | 4 | NIH | 4/9/2024 | $564,332 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | T32AI158105 | Training in HIV Persistence, Co-morbidities and Therapeutics | 000 | 4 | NIH | 7/23/2024 | $201,776 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01DC019369 | The Peripheral Vestibular System in Congenital Vestibular Disorders | 000 | 4 | NIH | 3/26/2024 | $333,273 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01DC019369 | The Peripheral Vestibular System in Congenital Vestibular Disorders | 001 | 4 | NIH | 5/29/2024 | $0 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS124477 | Novel pathogenic mechanism of HIV-associated CNS neurological disorders | 001 | 4 | NIH | 6/21/2024 | $22,325 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS124477 | Novel pathogenic mechanism of HIV-associated CNS neurological disorders | 000 | 4 | NIH | 5/8/2024 | $721,829 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA253013 | Digital Media for Cancer Control: Randomized Controlled Trial and Dose Response Effects | 000 | 5 | NIH | 5/21/2024 | $685,119 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01MH122712 | VTA microcircuit dynamics during chronic stress | 000 | 5 | NIH | 2/8/2024 | $409,775 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA240529 | Regulation of anti-tumor immunity by HDAC11 | 001 | 5 | NIH | 6/1/2024 | $10,782 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA240529 | Regulation of anti-tumor immunity by HDAC11 | 000 | 5 | NIH | 5/31/2024 | $535,034 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01CA246707 | Boosting Antitumor Immunity by Blocking Both Tumor and Adipose DDR1 | 000 | 5 | NIH | 4/12/2024 | $439,100 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01AI152770 | Quantifying the fitness cost of HIV-1 resistance to broadly neutralizing antibodies | 000 | 5 | NIH | 4/16/2024 | $721,590 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01AI153108 | CD4 dysfunction and cerebral toxoplasmosis | 000 | 4 | NIH | 5/13/2024 | $598,186 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01HL153154 | Effect of Hospital-Cardiologist Integration on Clinical Practice, Healthcare Quality, and Medicare Spending | 001 | 5 | NIH | 6/20/2024 | $49,765 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01HL153154 | Effect of Hospital-Cardiologist Integration on Clinical Practice, Healthcare Quality, and Medicare Spending | 000 | 5 | NIH | 4/26/2024 | $559,871 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R24AI152598 | The DC Cohort: A Longitudinal Population-Based Cohort Study of People Living with HIV in Washington, DC | 001 | 5 | NIH | 5/15/2024 | $4,667,321 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R25TW011505 | United States-Mali Research Ethics Training Program (US-Mali RETP) | 000 | 5 | NIH | 11/6/2023 | $144,580 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R25TW011505 | United States-Mali Research Ethics Training Program (US-Mali RETP) | 000 | 5 | NIH | 11/6/2023 | $100,000 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01MH122375 | Pragmatic Efficacy Trial of mHealth to Improve HIV Outcomes in the DC Cohort | 000 | 5 | NIH | 7/8/2024 | $640,780 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | UM1AI154466 | The District of Columbia Clinical Trials Unit (DC CTU) | 000 | 4 | NIH | 11/14/2023 | $653,078 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | UM1AI154466 | The District of Columbia Clinical Trials Unit (DC CTU) | 001 | 4 | NIH | 11/21/2023 | $0 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | UM1AI154466 | The District of Columbia Clinical Trials Unit (DC CTU) | 001 | 4 | NIH | 11/21/2023 | $0 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | UM1AI154466 | The District of Columbia Clinical Trials Unit (DC CTU) | 001 | 4 | NIH | 11/21/2023 | $0 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | UM1AI154466 | The District of Columbia Clinical Trials Unit (DC CTU) | 002 | 4 | NIH | 6/12/2024 | $26,015 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | UM1AI154466 | The District of Columbia Clinical Trials Unit (DC CTU) | 002 | 4 | NIH | 6/12/2024 | $653,077 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | UM1AI154466 | The District of Columbia Clinical Trials Unit (DC CTU) | 000 | 4 | NIH | 11/14/2023 | $26,016 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | UM1AI154466 | The District of Columbia Clinical Trials Unit (DC CTU) | 000 | 4 | NIH | 11/14/2023 | $335,600 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R37CA226171 | Engineered Ensemble Nanoimmunotherapies for Cancer | 001 | 6 | NIH | 4/15/2024 | $23,036 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R37CA226171 | Engineered Ensemble Nanoimmunotherapies for Cancer | 000 | 6 | NIH | 1/19/2024 | $414,671 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01NS106244 | Thalamic contributions to the developing EEG | 001 | 6 | NIH | 4/5/2024 | $473,849 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | 90PE0072 | Testing Innovative Methods to Project Impacts of Career Pathways Programs | 00 | 2 | ACF | 7/9/2024 | $99,444 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | F31AI186614 | PTPN1 and PTPN2 as targets to improve NK function against HIV | 001 | 1 | NIH | 6/21/2024 | $0 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | F31AI186614 | PTPN1 and PTPN2 as targets to improve NK function against HIV | 000 | 1 | NIH | 6/21/2024 | $43,756 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01AR082417 | The role of GPR84 signaling during skin repair | 001 | 2 | NIH | 6/13/2024 | $32,897 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01AR082417 | The role of GPR84 signaling during skin repair | 000 | 2 | NIH | 2/19/2024 | $422,959 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01HL133100 | Leptin signaling in the carotid body: mechanisms and consequences | 002 | 8 | NIH | 6/25/2024 | $46,733 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01HL133100 | Leptin signaling in the carotid body: mechanisms and consequences | 001 | 8 | NIH | 4/22/2024 | $204,887 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | R01HL133100 | Leptin signaling in the carotid body: mechanisms and consequences | 000 | 8 | NIH | 3/29/2024 | $525,746 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 002 | 10 | NIH | 6/6/2024 | $210,290 |
| 2024 | 2024 | GEORGE WASHINGTON UNIVERSITY (THE) | 1918 F ST NW | WASHINGTON | DC | 20052-0042 | DISTRICT OF COLUMBIA | USA | P30AI117970 | District of Columbia Center for AIDS Research | 004 | 10 | NIH | 6/10/2024 | $204,305 |
|